EUVIMEDEUVIMED entdecken
Crossref

Development of versatile solid-phase methods for syntheses of PROTACs with diverse E3 ligands

Hanqiao Xu, Takashi Kurohara, Nobumichi Ohoka, Genichiro Tsuji, Takao Inoue, Mikihiko Naito, Yosuke Demizu

Bioorganic & Medicinal Chemistry · 2023

DOI: 10.1016/j.bmc.2023.117293 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry, 2023. Verfasst von Hanqiao Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki, Kanagawa 210-9501, Japan; Graduate School of Medical Life Science, Yokohama City…. Hauptthemen laut MEDLINE: Nuclear Proteins, Transcription Factors, Proteolysis Targeting Chimera. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Developing highly active proteolysis-targeting chimeras (PROTACs) requires investigating a variety of ubiquitin ligase (E3 ligase) ligands and linker structures as well as their lengths. In this study, we developed a solid-phase synthesis method that affords PROTAC design diversity. We expanded the E3 ligand range to include Von Hippel-Lindau (VHL) and inhibitor of apoptosis protein (IAP) ligands because only the cereblon (CRBN) ligand thalidomide and its derivatives have been investigated for solid-phase synthesis of PROTACs. Moreover, we examined the suitability of a polyethylene glycol (PEG) rather than an alkyl linker used in our previous study for synthesizing PROTACs. Facile and rapid solid-phase synthesis methods using the above E3 ligands for developing PROTACs targeting bromodomain-containing protein 4 (BRD4) were accomplished. Western blotting analysis revealed that minor differences in the E3 ligand and linker type significantly affected the activity of the synthesized PROTACs. Our solid-phase PROTAC synthesis methods enable rapid synthesis of multiple PROTACs with various combinations of ligands for the protein-of-interest and E3 ligands and linkers that connect these ligands.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nuclear ProteinsTranscription FactorsProteolysis Targeting ChimeraLigandsProteolysisUbiquitin-Protein Ligases

Substanzen

LigandsNuclear ProteinsTranscription FactorsUbiquitin-Protein LigasesProteolysis Targeting Chimera

Autor:innen und Institutionen

  • National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki, Kanagawa 210-9501, Japan; Graduate School of Medical Life Science, Yokohama City University, 1-7-29, Yokohama, Kanagawa 230-0045, Japan.
  • National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki, Kanagawa 210-9501, Japan.
  • Laboratory of Targeted Protein Degradation, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-0033, Japan.
  • National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki, Kanagawa 210-9501, Japan; Graduate School of Medical Life Science, Yokohama City University, 1-7-29, Yokohama, Kanagawa 230-0045, Japan; Graduate Scho…

Zitieren

APA

Xu, H., Kurohara, T., Ohoka, N., Tsuji, G., Inoue, T., Naito, M., & Demizu, Y. (2023). Development of versatile solid-phase methods for syntheses of PROTACs with diverse E3 ligands. Bioorganic & Medicinal Chemistry. https://doi.org/10.1016/j.bmc.2023.117293

Vancouver

Xu H, Kurohara T, Ohoka N, Tsuji G, Inoue T, Naito M, et al. Development of versatile solid-phase methods for syntheses of PROTACs with diverse E3 ligands. Bioorganic & Medicinal Chemistry. 2023. doi:10.1016/j.bmc.2023.117293

BibTeX
@article{Xu2023,
  author = {Xu, Hanqiao and Kurohara, Takashi and Ohoka, Nobumichi and Tsuji, Genichiro and Inoue, Takao and Naito, Mikihiko and Demizu, Yosuke},
  title = {Development of versatile solid-phase methods for syntheses of PROTACs with diverse E3 ligands},
  journal = {Bioorganic & Medicinal Chemistry},
  year = {2023},
  doi = {10.1016/j.bmc.2023.117293}
}
Kostenlos starten →